Anti-CD44 monoclonal antibody KM81

Drug Profile

Anti-CD44 monoclonal antibody KM81

Alternative Names: KM81

Latest Information Update: 26 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Antirheumatics; Monoclonal antibodies
  • Mechanism of Action CD44 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Graft-versus-host disease; Rheumatoid arthritis

Most Recent Events

  • 18 Aug 1998 No-Development-Reported for Graft-versus-host disease in USA (Unknown route)
  • 31 Jul 1997 Preclinical development for Rheumatoid arthritis in USA (Unknown route)
  • 31 Mar 1994 Preclinical development for Graft-versus-host disease in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top